MTND5P13

Across TCGA pan-cancer cohorts, MTND5P13 RNA is linked to patient survival in 12 of 34 cancer types, making it the most broadly survival-associated MTND5P13 data layer.

The strongest signal is observed in stomach adenocarcinoma (STAD), where higher MTND5P13 RNA is associated with worse disease-free survival. In most high-consensus cancer types, elevated MTND5P13 expression acts as an unfavorable survival marker, although some lineages such as BLCA and LIHC show a favorable association.

STAD, UCS, and DLBC are the cancer types where MTND5P13 RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
STAD	DFS	Quartile	II,III,IV	0.490	0.686	<.001	85	view →
UCS	OS	Tertile	All	0.263	0.712	<.001	72	view →
DLBC	DFS	Tertile	II,III,IV	0.065	0.829	<.001	54	view →
TGCT	DFS	Tertile	All	0.046	0.674	<.001	36	view →
BLCA	OS	Tertile	II,III,IV	1.000	0.421	.020	30	view →
GBM	DFS	Tertile	All	0.066	0.292	<.001	18	view →
UCEC	DFS	Tertile	IV	0.206	0.704	.033	18	view →
KIRP	OS	Tertile	II,III,IV	0.601	0.873	.021	15	view →
LIHC	DFS	Tertile	II,III,IV	1.000	0.419	.016	9	view →
KIRC	OS	Tertile	All	0.777	0.879	.044	6	view →
THCA	OS	Tertile	All	0.613	0.958	.046	6	view →
LGG	DFS	Tertile	All	0.205	0.435	.029	3	view →

Pink = unfavorable, green = favorable. Showing the 12 strongest of 12 lineages.

MTND5P13–STAD (DFS)

Open the STAD breakdown →